Brief: Painreform Provides Year-End Business Update On Track To Commence Phase 3 Trial Of Prf-110 For Non-Opiate Post-Operative Pain Relief In Second Half Of 2022
17/03/2022 13:36
March 17 (Reuters) - PainReform Ltd PRFX.O :
* PAINREFORM PROVIDES YEAR-END BUSINESS UPDATE; ON TRACK TO
COMMENCE PHASE 3 TRIAL OF PRF-110 FOR NON-OPIATE POST-OPERATIVE
PAIN RELIEF IN SECOND HALF OF 2022
Source text for Eikon: ID:nGNX6zV78c
Further company coverage: PRFX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on PRF Technologies
See all newsBrief: Prf Technologies S.H.N. Financial Investments Seeks Special General Meeting At Prf Technologies To Remove Directors, Appoint Three S.H.N. Nominees
U.S. STOCKS ON THE MOVE-Bumble, Tempus AI, TD Synnex
U.S. STOCKS ON THE MOVE-Bio-Techne, IBM, Apple
PRF Technologies rises as animal study shows pain drug matches approved rival
U.S. STOCKS ON THE MOVE-Wendy's, Canadian Solar, Bio-Techne